id,source,text,arguments
0,EGRAM,A caspase-2 minigene construct could be made that is alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
1,EGRAM,A caspase-2 minigene construct could be made that is spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
2,EGRAM,A caspase-2 minigene construct could be made to be alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
3,EGRAM,A caspase-2 minigene construct could be made to be spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
4,EGRAM,A caspase-2 minigene construct has been made that can be spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
5,EGRAM,A caspase-2 minigene construct has been shown to be made that is alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
6,EGRAM,A caspase-2 minigene construct has been shown to be made that is spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
7,EGRAM,A caspase-2 minigene construct has the ability to be made to be alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
8,EGRAM,A caspase-2 minigene construct has the ability to be made to be spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
9,EGRAM,A caspase-2 minigene construct is able to be made that is alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
10,EGRAM,A caspase-2 minigene construct is able to be made that is spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
11,EGRAM,A caspase-2 minigene construct is made that can be alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
12,EGRAM,A caspase-2 minigene construct is made that can be spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
13,EGRAM,A caspase-2 minigene construct is observed to be made that is alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
14,EGRAM,A caspase-2 minigene construct is observed to be made that is spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
15,EGRAM,A caspase-2 minigene construct may be made that was alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
16,EGRAM,A caspase-2 minigene construct may be made that was spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
17,EGRAM,A caspase-2 minigene construct may have been made that can be alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
18,EGRAM,A caspase-2 minigene construct may have been made that can be spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
19,EGRAM,A caspase-2 minigene construct was made that was alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
20,EGRAM,A caspase-2 minigene construct was made that was spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
21,EGRAM,A caspase-2 minigene construct will be made that is alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
22,EGRAM,A caspase-2 minigene construct will be made that is spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
23,EGRAM,A caspase-2 minigene construct would be made that could be alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
24,EGRAM,A caspase-2 minigene construct would be made that could be spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
25,EGRAM,"A pre-mRNA containing mutations in SE2, however, can be alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
26,EGRAM,"A pre-mRNA containing mutations in SE2, however, has been alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
27,EGRAM,"A pre-mRNA containing mutations in SE2, however, has been shown to be alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
28,EGRAM,"A pre-mRNA containing mutations in SE2, however, has the ability to be alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
29,EGRAM,"A pre-mRNA containing mutations in SE2, however, is able to alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
30,EGRAM,"A pre-mRNA containing mutations in SE2, however, is alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
31,EGRAM,"A pre-mRNA containing mutations in SE2, however, is likely to be alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
32,EGRAM,"A pre-mRNA containing mutations in SE2, however, is observed to be alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
33,EGRAM,"A pre-mRNA containing mutations in SE2, however, may have been alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
34,EGRAM,"A pre-mRNA containing mutations in SE2, however, was alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
35,EGRAM,"A pre-mRNA containing mutations in SE2, however, will be alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
36,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I alternatively splices only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
37,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I can alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
38,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I can splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
39,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has alternatively spliced only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
40,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has been shown to alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
41,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has been shown to splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
42,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has spliced only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
43,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has the ability to alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
44,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has the ability to splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
45,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I is able to alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
46,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I is able to splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
47,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I is observed to alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
48,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I is observed to splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
49,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I may have alternatively spliced only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
50,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I may have spliced only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
51,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I splices only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
52,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I will alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
53,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I will splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
54,EGRAM,"Consequently, exon 30 with the intron can be spliced.",{'1': 'exon 30 with the intron'}
55,EGRAM,"Consequently, exon 30 with the intron has been shown to be spliced.",{'1': 'exon 30 with the intron'}
56,EGRAM,"Consequently, exon 30 with the intron has been spliced.",{'1': 'exon 30 with the intron'}
57,EGRAM,"Consequently, exon 30 with the intron has the ability to be spliced.",{'1': 'exon 30 with the intron'}
58,EGRAM,"Consequently, exon 30 with the intron is able to be spliced.",{'1': 'exon 30 with the intron'}
59,EGRAM,"Consequently, exon 30 with the intron is observed to be spliced.",{'1': 'exon 30 with the intron'}
60,EGRAM,"Consequently, exon 30 with the intron may have been spliced.",{'1': 'exon 30 with the intron'}
61,EGRAM,"Consequently, exon 30 with the intron was spliced.",{'1': 'exon 30 with the intron'}
62,EGRAM,"Consequently, exon 30 with the intron will be spliced.",{'1': 'exon 30 with the intron'}
63,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, can be spliced.","{'1': 'exon 30 with the intron, as our study suggested,'}"
64,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, has been shown to be spliced.","{'1': 'exon 30 with the intron, as our study suggested,'}"
65,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, has been spliced.","{'1': 'exon 30 with the intron, as our study suggested,'}"
66,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, has the ability to be spliced.","{'1': 'exon 30 with the intron, as our study suggested,'}"
67,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, is able to be spliced.","{'1': 'exon 30 with the intron, as our study suggested,'}"
68,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, is observed to be spliced.","{'1': 'exon 30 with the intron, as our study suggested,'}"
69,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, may have been spliced.","{'1': 'exon 30 with the intron, as our study suggested,'}"
70,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, was spliced.","{'1': 'exon 30 with the intron, as our study suggested,'}"
71,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, will be spliced.","{'1': 'exon 30 with the intron, as our study suggested,'}"
72,EGRAM,Exons outside this size range are able to require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
73,EGRAM,Exons outside this size range are able to require additional exonic and/or intronic sequences to be spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
74,EGRAM,Exons outside this size range are effectively spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
75,EGRAM,Exons outside this size range are observed to require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
76,EGRAM,Exons outside this size range are observed to require additional exonic and/or intronic sequences to be spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
77,EGRAM,Exons outside this size range are spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
78,EGRAM,Exons outside this size range have been effectively spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
79,EGRAM,Exons outside this size range have been shown to require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
80,EGRAM,Exons outside this size range have been shown to require additional exonic and/or intronic sequences to be spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
81,EGRAM,Exons outside this size range have been spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
82,EGRAM,Exons outside this size range have required additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
83,EGRAM,Exons outside this size range have required additional exonic and/or intronic sequences to be spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
84,EGRAM,Exons outside this size range have the probability of requiring additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
85,EGRAM,Exons outside this size range have the probability of requiring additional exonic and/or intronic sequences to be spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
86,EGRAM,Exons outside this size range may have required additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
87,EGRAM,Exons outside this size range may have required additional exonic and/or intronic sequences to be spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
88,EGRAM,Exons outside this size range may require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
89,EGRAM,Exons outside this size range may require additional exonic and/or intronic sequences to be spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
90,EGRAM,Exons outside this size range require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
91,EGRAM,Exons outside this size range require additional exonic and/or intronic sequences to be spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
92,EGRAM,Exons outside this size range required additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
93,EGRAM,Exons outside this size range required additional exonic and/or intronic sequences to be spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
94,EGRAM,Exons outside this size range were effectively spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
95,EGRAM,Exons outside this size range were spliced into the mature mRNA.,"{'1': 'exons outside this size range', '2': 'the mature mRNA'}"
96,EGRAM,"However, a pre-mRNA containing mutations in SE2 can be alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
97,EGRAM,"However, a pre-mRNA containing mutations in SE2 can be spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
98,EGRAM,"However, a pre-mRNA containing mutations in SE2 has been alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
99,EGRAM,"However, a pre-mRNA containing mutations in SE2 has been shown to be alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
100,EGRAM,"However, a pre-mRNA containing mutations in SE2 has been shown to be spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
101,EGRAM,"However, a pre-mRNA containing mutations in SE2 has been spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
102,EGRAM,"However, a pre-mRNA containing mutations in SE2 has the ability to be alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
103,EGRAM,"However, a pre-mRNA containing mutations in SE2 has the ability to be spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
104,EGRAM,"However, a pre-mRNA containing mutations in SE2 is able to alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
105,EGRAM,"However, a pre-mRNA containing mutations in SE2 is able to spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
106,EGRAM,"However, a pre-mRNA containing mutations in SE2 is alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
107,EGRAM,"However, a pre-mRNA containing mutations in SE2 is likely to be alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
108,EGRAM,"However, a pre-mRNA containing mutations in SE2 is likely to be spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
109,EGRAM,"However, a pre-mRNA containing mutations in SE2 is observed to be alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
110,EGRAM,"However, a pre-mRNA containing mutations in SE2 is observed to be spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
111,EGRAM,"However, a pre-mRNA containing mutations in SE2 may have been alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
112,EGRAM,"However, a pre-mRNA containing mutations in SE2 may have been spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
113,EGRAM,"However, a pre-mRNA containing mutations in SE2 was alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
114,EGRAM,"However, a pre-mRNA containing mutations in SE2 was spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
115,EGRAM,"However, a pre-mRNA containing mutations in SE2 will be alternatively spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
116,EGRAM,"However, a pre-mRNA containing mutations in SE2 will be spliced predominantly using the nt 3605 3 splice site.","{'0': 'a pre-mRNA containing mutations in SE2', '1': 'the nt 3605 3 splice site'}"
117,EGRAM,The Supt4h gene can be normally spliced from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
118,EGRAM,The Supt4h gene can be spliced normally from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
119,EGRAM,The Supt4h gene has been normally spliced from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
120,EGRAM,The Supt4h gene has been shown to be normally spliced from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
121,EGRAM,The Supt4h gene has been shown to be spliced normally from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
122,EGRAM,The Supt4h gene has been spliced normally from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
123,EGRAM,The Supt4h gene has the ability to be normally spliced from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
124,EGRAM,The Supt4h gene has the ability to be spliced normally from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
125,EGRAM,The Supt4h gene is able to be normally spliced from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
126,EGRAM,The Supt4h gene is able to be spliced normally from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
127,EGRAM,The Supt4h gene is likely to be normally spliced from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
128,EGRAM,The Supt4h gene is likely to be spliced normally from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
129,EGRAM,The Supt4h gene is observed to be normally spliced from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
130,EGRAM,The Supt4h gene is observed to be spliced normally from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
131,EGRAM,The Supt4h gene may be normally spliced from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons'}"
132,EGRAM,The Supt4h gene may be spliced normally from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons'}"
133,EGRAM,The Supt4h gene may have been normally spliced from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
134,EGRAM,The Supt4h gene may have been spliced normally from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
135,EGRAM,The Supt4h gene was normally spliced from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
136,EGRAM,The Supt4h gene was spliced normally from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
137,EGRAM,The Supt4h gene will be normally spliced from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
138,EGRAM,The Supt4h gene will be spliced normally from five exons encoded by chromosome 11.,"{'0': 'The Supt4h gene', '1': 'five exons encoded by chromosome 11'}"
139,EGRAM,"The casp-2 minigene (C2) can be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
140,EGRAM,"The casp-2 minigene (C2) can be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
141,EGRAM,"The casp-2 minigene (C2) has been efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
142,EGRAM,"The casp-2 minigene (C2) has been spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
143,EGRAM,"The casp-2 minigene (C2) has the ability to be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
144,EGRAM,"The casp-2 minigene (C2) has the ability to be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
145,EGRAM,"The casp-2 minigene (C2) is able to be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
146,EGRAM,"The casp-2 minigene (C2) is able to be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
147,EGRAM,"The casp-2 minigene (C2) is efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
148,EGRAM,"The casp-2 minigene (C2) is observed to be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
149,EGRAM,"The casp-2 minigene (C2) is observed to be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
150,EGRAM,"The casp-2 minigene (C2) is spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
151,EGRAM,"The casp-2 minigene (C2) may have been efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
152,EGRAM,"The casp-2 minigene (C2) may have been shown to be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
153,EGRAM,"The casp-2 minigene (C2) may have been shown to be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
154,EGRAM,"The casp-2 minigene (C2) may have been spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
155,EGRAM,"The casp-2 minigene (C2) will be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
156,EGRAM,"The casp-2 minigene (C2) will be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
157,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon being able to be efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
158,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon being able to be spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
159,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon being efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
160,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon being spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
161,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
162,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon having been efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
163,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon having been spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
164,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon having the ability to be efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
165,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon having the ability to be spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
166,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon observed to be efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
167,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon observed to be spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
168,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon shown to be efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
169,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon shown to be spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
170,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
171,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that can be efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
172,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that can be spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
173,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
174,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been shown to be efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
175,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been shown to be spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
176,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
177,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has the ability to be efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
178,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has the ability to be spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
179,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is able to be efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
180,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is able to be spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
181,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is observed to be efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
182,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is observed to be spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
183,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that may have been efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
184,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that may have been spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
185,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that was efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
186,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that was spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
187,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that will be efficiently spliced into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
188,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that will be spliced efficiently into the mRNA.,"{'1': 'a 654 nt exon', '2': 'the mRNA'}"
189,EGRAM,"The pre-mRNAs from all of these genes are able to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.","{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
190,EGRAM,"The pre-mRNAs from all of these genes are observed to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.","{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
191,EGRAM,The pre-mRNAs from all of these genes being able to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
192,EGRAM,"The pre-mRNAs from all of these genes can be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.","{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
193,EGRAM,"The pre-mRNAs from all of these genes have been shown to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.","{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
194,EGRAM,"The pre-mRNAs from all of these genes have been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.","{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
195,EGRAM,"The pre-mRNAs from all of these genes have the ability to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.","{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
196,EGRAM,The pre-mRNAs from all of these genes having been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
197,EGRAM,The pre-mRNAs from all of these genes having the ability to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
198,EGRAM,"The pre-mRNAs from all of these genes may have been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.","{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
199,EGRAM,The pre-mRNAs from all of these genes observed to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
200,EGRAM,The pre-mRNAs from all of these genes shown to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
201,EGRAM,The pre-mRNAs from all of these genes spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
202,EGRAM,The pre-mRNAs from all of these genes that are able to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
203,EGRAM,The pre-mRNAs from all of these genes that are observed to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
204,EGRAM,The pre-mRNAs from all of these genes that can be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
205,EGRAM,The pre-mRNAs from all of these genes that have been shown to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
206,EGRAM,The pre-mRNAs from all of these genes that have been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
207,EGRAM,The pre-mRNAs from all of these genes that have the ability to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
208,EGRAM,The pre-mRNAs from all of these genes that may have been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
209,EGRAM,The pre-mRNAs from all of these genes that were spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
210,EGRAM,The pre-mRNAs from all of these genes that will be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,"{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
211,EGRAM,"The pre-mRNAs from all of these genes were spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.","{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
212,EGRAM,"The pre-mRNAs from all of these genes will be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.","{'0': 'The pre-mRNAs from all of these genes', '1': 'little or no exon-skipping'}"
213,EGRAM,"The structure of different cDNA clones indicates that USF RNA can be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
214,EGRAM,"The structure of different cDNA clones indicates that USF RNA can be spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
215,EGRAM,"The structure of different cDNA clones indicates that USF RNA has been differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
216,EGRAM,"The structure of different cDNA clones indicates that USF RNA has been shown to be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
217,EGRAM,"The structure of different cDNA clones indicates that USF RNA has been shown to be spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
218,EGRAM,"The structure of different cDNA clones indicates that USF RNA has been spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
219,EGRAM,"The structure of different cDNA clones indicates that USF RNA has the ability to be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
220,EGRAM,"The structure of different cDNA clones indicates that USF RNA has the ability to be spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
221,EGRAM,"The structure of different cDNA clones indicates that USF RNA is able to be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
222,EGRAM,"The structure of different cDNA clones indicates that USF RNA is able to be spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
223,EGRAM,"The structure of different cDNA clones indicates that USF RNA is observed to be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
224,EGRAM,"The structure of different cDNA clones indicates that USF RNA is observed to be spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
225,EGRAM,"The structure of different cDNA clones indicates that USF RNA may have been differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
226,EGRAM,"The structure of different cDNA clones indicates that USF RNA may have been spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
227,EGRAM,"The structure of different cDNA clones indicates that USF RNA was differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
228,EGRAM,"The structure of different cDNA clones indicates that USF RNA was spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
229,EGRAM,"The structure of different cDNA clones indicates that USF RNA will be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
230,EGRAM,"The structure of different cDNA clones indicates that USF RNA will be spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
231,EGRAM,We also identified four transcriptional units being able to be differentially spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
232,EGRAM,We also identified four transcriptional units being able to be spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
233,EGRAM,We also identified four transcriptional units differentially spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
234,EGRAM,We also identified four transcriptional units having been shown to be differentially spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
235,EGRAM,We also identified four transcriptional units having been shown to be spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
236,EGRAM,We also identified four transcriptional units observed to be differentially spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
237,EGRAM,We also identified four transcriptional units observed to be spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
238,EGRAM,We also identified four transcriptional units spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
239,EGRAM,We also identified four transcriptional units that are able to be differentially spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
240,EGRAM,We also identified four transcriptional units that are able to be spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
241,EGRAM,We also identified four transcriptional units that are observed to be differentially spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
242,EGRAM,We also identified four transcriptional units that are observed to be spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
243,EGRAM,We also identified four transcriptional units that can be differentially spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
244,EGRAM,We also identified four transcriptional units that can be spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
245,EGRAM,We also identified four transcriptional units that could have been differentially spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
246,EGRAM,We also identified four transcriptional units that could have been spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
247,EGRAM,We also identified four transcriptional units that have been differentially spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
248,EGRAM,We also identified four transcriptional units that have been shown to be differentially spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
249,EGRAM,We also identified four transcriptional units that have been shown to be spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
250,EGRAM,We also identified four transcriptional units that have been spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
251,EGRAM,We also identified four transcriptional units that may be differentially spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
252,EGRAM,We also identified four transcriptional units that may be spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
253,EGRAM,We also identified four transcriptional units that may have been differentially spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
254,EGRAM,We also identified four transcriptional units that may have been spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
255,EGRAM,We also identified four transcriptional units that were differentially spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
256,EGRAM,We also identified four transcriptional units that were spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
257,EGRAM,We also identified four transcriptional units that will be differentially spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
258,EGRAM,We also identified four transcriptional units that will be spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
259,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate can be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
260,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate can be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
261,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has been shown to be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
262,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has been shown to be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
263,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has been spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
264,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has been spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
265,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has the ablity to be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
266,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has the ablity to be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
267,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is able to be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
268,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is able to be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
269,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is observed to be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
270,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is observed to be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
271,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
272,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
273,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate may be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
274,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate may be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
275,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate may have been spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
276,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate may have been spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
277,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate will be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
278,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate will be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).","{'0': 'the C2Gloi2 substrate', '1': 'the exon-skipping pathway'}"
